WMT

116.36

-0.47%↓

COST

959.88

-1%↓

147.29

-0.63%↓

TGT

101.3

-2.85%↓

61.62

-0.58%↓

WMT

116.36

-0.47%↓

COST

959.88

-1%↓

147.29

-0.63%↓

TGT

101.3

-2.85%↓

61.62

-0.58%↓

WMT

116.36

-0.47%↓

COST

959.88

-1%↓

147.29

-0.63%↓

TGT

101.3

-2.85%↓

61.62

-0.58%↓

WMT

116.36

-0.47%↓

COST

959.88

-1%↓

147.29

-0.63%↓

TGT

101.3

-2.85%↓

61.62

-0.58%↓

WMT

116.36

-0.47%↓

COST

959.88

-1%↓

147.29

-0.63%↓

TGT

101.3

-2.85%↓

61.62

-0.58%↓

Home・Akcijų sąrašas・USANA Health Sciences Inc

USANA Health Sciences Inc

Atidarymo kaina

21.47 -3.07

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

21.57

Max

22.15

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-17M -6.7M
Pardavimai	-22M 214M
P/E Sektoriaus vid.	24.689 29.619
Pelnas, tenkantis vienai akcijai	-0.15
Pelno marža	-3.118
Darbuotojai	1,700
EBITDA	-17M 11M

Dividendai
By Dow Jones
Kitas uždarbis	2026-02-17

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	25M 406M
Ankstesnė atidarymo kaina	24.54
Ankstesnė uždarymo kaina	21.47

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

28.405 / 29.84 Palaikymas ir pasipriešinimas

USANA Health Sciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-27 23:07; UTC

Uždarbis

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

2026-01-27 21:27; UTC

Uždarbis

Texas Instruments 4Q Sales Rise, Profit Falls

2026-01-27 23:55; UTC

Rinkos pokalbiai

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

2026-01-27 23:47; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-01-27 23:47; UTC

Rinkos pokalbiai

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

2026-01-27 23:39; UTC

Rinkos pokalbiai

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

2026-01-27 23:20; UTC

Uždarbis

SK Innovation: Asset-Impairment Losses Weighed on Earnings

2026-01-27 23:20; UTC

Uždarbis

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

2026-01-27 23:19; UTC

Uždarbis

SK Innovation Posts Net Loss for Second Consecutive Year

2026-01-27 23:19; UTC

Uždarbis

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

2026-01-27 23:18; UTC

Uždarbis

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

2026-01-27 23:18; UTC

Uždarbis

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

2026-01-27 23:11; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-01-27 23:11; UTC

Rinkos pokalbiai

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

2026-01-27 23:07; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

2026-01-27 22:17; UTC

Rinkos pokalbiai

U.S. Dollar Slips Following Trump Comments -- Market Talk

2026-01-27 22:06; UTC

Uždarbis

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

2026-01-27 21:51; UTC

Uždarbis

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

2026-01-27 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-01-27 21:43; UTC

Uždarbis

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

2026-01-27 21:41; UTC

Uždarbis

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

2026-01-27 21:38; UTC

Uždarbis

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

2026-01-27 21:32; UTC

Uždarbis

Ampol: Modest Profit From F&I International in 2025

2026-01-27 21:32; UTC

Uždarbis

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

2026-01-27 21:31; UTC

Uždarbis

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

2026-01-27 21:31; UTC

Uždarbis

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

2026-01-27 21:30; UTC

Uždarbis

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

2026-01-27 21:29; UTC

Uždarbis

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

2026-01-27 21:29; UTC

Uždarbis

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

2026-01-27 21:28; UTC

Uždarbis

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Akcijų palyginimas

Kainos pokytis

USANA Health Sciences Inc Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių USANA Health Sciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

28.405 / 29.84Palaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.